Compare ARK Genomic Revolution ETF (ARKG) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs EPR Properties — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while EPR Properties trades at $59.75 (market cap $4.56B). The key difference: EPR Properties pays a 6.24% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | EPR | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $61.21 |
52-Week Low | $23.09 | $48.71 |
Market Cap | — | $4.56B |
Enterprise Value | — | $7.62B |
Dividend Yield | — | 6.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EPR Properties trades at $59.62, up 0.08% on the day, with a bullish technical signal from moving averages. The REIT shows strong profitability with a 39.93% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights a $315 million Six Flags acquisition and monthly dividends, reinforcing its experiential real estate focus.
Outlook remains positive with a consensus price target of $63.00, though risks include portfolio transition execution and sensitivity to consumer discretionary spending. The stock offers a 6%+ yield with solid coverage, appealing for income investors amid stable occupancy and growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
